Tang Capital Management’s Dianthus Therapeutics DNTH Stock Holding History

Tang Capital Management’s Portfolio DNTH Stock Details DNTH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$25.8M	Hold	264,692	–	–	1.17%	21
2026 Q1	$22.2M	Hold	264,692	–	–	1.13%	22
2025 Q4	$10.9M	Hold	264,692	–	–	0.54%	35
2025 Q3	$10.4M	Hold	264,692	–	–	0.4%	64
2025 Q2	$4.93M	Hold	264,692	–	–	0.25%	84
2025 Q1	$4.8M	Hold	264,692	–	–	0.27%	75
2024 Q4	$5.77M	Hold	264,692	–	–	0.38%	64
2024 Q3	$7.25M	Hold	264,692	–	–	0.52%	57
2024 Q2	$6.85M	Hold	264,692	–	–	0.7%	45
2024 Q1	$7.94M	Sell	264,692 -239,550	-48%	-$5.21M	0.83%	42
2023 Q4	$5.24M	Sell	504,242 -87,394	-15%	-$965K	0.48%	52
2023 Q3	$8.09M	Buy	591,636 +212,886	+56%	+$2.68M	1.14%	29
2023 Q2	$4.59M	Buy	378,750 +625	+0.2%	+$7.11K	0.68%	40
2023 Q1	$4.81M	Buy	+378,125	New	+$4.19M	0.72%	44

Other funds holding DNTH

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

FFM

Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

APM

Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return

OCA

Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return

Tang Capital Management's DNTH Position: Q2 2026 in Review

Tang Capital Management held its Dianthus Therapeutics (DNTH) position steady in Q2 2026 at 264,692 shares worth $25.8M. The position accounts for 1.17% of the portfolio, ranked #21.

Tang Capital Management first reported a position in DNTH in Q1 2023 and has held it in 14 quarters since. 269 funds tracked by Wall St. Rank hold DNTH as of Q2 2026.

Tang Capital Management held 264,692 shares of Dianthus Therapeutics worth $25.8M as of Q2 2026.
Tang Capital Management left its Dianthus Therapeutics share count unchanged in Q2 2026.
Dianthus Therapeutics made up 1.17% of Tang Capital Management's portfolio in Q2 2026, its #21 holding.
Tang Capital Management first reported a position in Dianthus Therapeutics in Q1 2023 and has held it in 14 quarters since.
269 funds tracked by Wall St. Rank held Dianthus Therapeutics as of Q2 2026.

Based on Tang Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.